Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 4006-4007

Blackwell Publishing

Access to resources Recommend Favorite

Cyclophosphamide/fludarabine/rituximab: Fatal progressive multifocal leukoencephalopathy and toxoplasmosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1319, 2010-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Rituximab: Progressive multifocal leukoencephalopathy in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1179, 2007-01 ,pp. : 30-31

Adis International

Access to resources Recommend Favorite

Rituximab: Progressive multifocal leukoencephalopathy in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1276, 2009-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma

By Chen Yi-Bin   Batchelor Tracy   Li Shuli   Hochberg Ephraim   Brezina Mark   Jones Sooae   Del Rio Candice   Curtis Morgan   Ballen Karen K.   Barnes Jeffrey   Chi Andrew S.   Dietrich Jorg   Driscoll Jessica   Gertsner Elizabeth R.   Hochberg Fred   LaCasce Ann S.   McAfee Steven L.   Spitzer Thomas R.   Nayak Lakshmi   Armand Philippe  

Cancer, Vol. 121, Iss. 2, 2015-01 ,pp. : 226-233

Blackwell Publishing

Access to resources Recommend Favorite